[{"id":"5ce9e5b0-8c58-45f4-97dd-dbdaf31eacc1","acronym":"","url":"https://clinicaltrials.gov/study/NCT05713279","created_at":"2023-02-06T15:02:33.352Z","updated_at":"2024-07-02T16:35:35.740Z","phase":"","brief_title":"Study of Flonoltinib Maleate Tablets in the Treatment of Severe Novel Coronavirus (COVID-19) Infection","source_id_and_acronym":"NCT05713279","lead_sponsor":"Chengdu Zenitar Biomedical Technology Co., Ltd","biomarkers":" IL6","pipe":"","alterations":" ","tags":["IL6"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e flonoltinib"],"overall_status":"Active, not recruiting","enrollment":" Enrollment 66","initiation":"Initiation: 01/19/2023","start_date":" 01/19/2023","primary_txt":" Primary completion: 11/01/2023","primary_completion_date":" 11/01/2023","study_txt":" Completion: 11/30/2023","study_completion_date":" 11/30/2023","last_update_posted":"2023-09-26"}]